Details for New Drug Application (NDA): 209846
✉ Email this page to a colleague
The generic ingredient in CLINDAMYCIN PHOSPHATE is clindamycin phosphate; tretinoin. There are fifty-five drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the clindamycin phosphate; tretinoin profile page.
Summary for 209846
Tradename: | CLINDAMYCIN PHOSPHATE |
Applicant: | Chartwell Rx |
Ingredient: | clindamycin phosphate |
Patents: | 0 |
Pharmacology for NDA: 209846
Physiological Effect | Decreased Sebaceous Gland Activity Neuromuscular Blockade |
Suppliers and Packaging for NDA: 209846
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 209846 | ANDA | A-S Medication Solutions | 50090-5779 | 50090-5779-0 | 1 BOTTLE, WITH APPLICATOR in 1 CARTON (50090-5779-0) / 60 mL in 1 BOTTLE, WITH APPLICATOR |
CLINDAMYCIN PHOSPHATE | clindamycin phosphate | SOLUTION;TOPICAL | 209846 | ANDA | Glasshouse Pharmaceuticals Limited Canada | 71428-003 | 71428-003-30 | 1 BOTTLE in 1 CARTON (71428-003-30) / 30 mL in 1 BOTTLE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | SOLUTION;TOPICAL | Strength | EQ 1% BASE | ||||
Approval Date: | Feb 8, 2018 | TE: | AT | RLD: | No |
Complete Access Available with Subscription